|| common in complete genomics
|?|| (C;C) (C;T) (T;T) ||28|
indicates that this SNP is relevant to Warfarin
dosing. rs339097(G) is associated with 14.5% higher therapeutic warfarin dose in African Americans. This variant is also more common in African Americans with minor allele frequencies of 11–14% , but only 0.2% in Caucasians.
[PMID 21228733] Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.
|| Insufficiently evaluated pharmacogenetic
[PMID 22676711] Pharmacogenomics of warfarin in populations of African descent.